Catalyst Biosciences, Inc. (CBIO) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$11.81
Day's range
$12.3

Crescent Biopharma Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 08/13/2026 4.13 M $74.40 M   0.00% 13.54%
BVF INC/IL 08/14/2026 2.75 M $49.48 M   0.00% 9.00%
FAIRMOUNT FUNDS MANAGEMENT LLC 08/14/2026 2.75 M $49.46 M   0.00% 9.00%
VR ADVISER, LLC 08/14/2026 2.13 M $38.40 M   0.00% 6.99%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 1.90 M $34.20 M   293.78% 6.22%
FCPM III SERVICES B.V. 08/14/2026 1.68 M $30.20 M   0.00% 5.50%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 1.66 M $29.93 M   10.12% 5.45%
VESTAL POINT CAPITAL, LP 08/14/2026 1.63 M $29.34 M   8.67% 5.34%
OPALEYE MANAGEMENT INC. 08/14/2026 1.32 M $23.75 M   0.51% 4.32%
BLACKROCK, INC. 08/07/2026 1.27 M $22.89 M   998.95% 4.17%
TANG CAPITAL MANAGEMENT LLC 08/14/2026 1.16 M $20.88 M   0.00% 3.80%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 767.76 K $13.82 M   -4.20% 2.51%
MILLENNIUM MANAGEMENT LLC 08/14/2026 403.86 K $7.27 M   24.82% 1.32%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 384.58 K $6.92 M   269.00% 1.26%
JENNISON ASSOCIATES LLC 08/03/2026 378.51 K $6.81 M   147.43% 1.24%
RTW INVESTMENTS, LP 08/14/2026 372.86 K $6.71 M   0.00% 1.22%
NEXTBIO CAPITAL MANAGEMENT LP 08/14/2026 372.86 K $6.71 M   0.00% 1.22%
REMEDIUM CAPITAL PARTNERS, LLC 08/07/2026 361.25 K $6.50 M   100.00% 1.18%
STATE STREET CORP 09/22/2026 315.59 K $5.68 M   707.81% 1.03%
AMERIPRISE FINANCIAL INC 08/14/2026 302.57 K $5.45 M   100.00% 0.99%
POINT72 ASSET MANAGEMENT, L.P. 08/14/2026 300.00 K $5.40 M   0.00% 0.98%
PRICE T ROWE ASSOCIATES INC /MD/ 08/14/2026 275.58 K $4.96 M   -9.21% 0.90%
MARSHALL WACE, LLP 08/13/2026 214.30 K $3.86 M   6.73% 0.70%
PERCEPTIVE ADVISORS LLC 08/14/2026 206.94 K $3.72 M   0.00% 0.68%
VANGUARD PORTFOLIO MANAGEMENT LLC 08/13/2026 188.80 K $3.40 M   100.00% 0.62%
TWO SIGMA INVESTMENTS, LP 08/14/2026 186.87 K $3.36 M   61.34% 0.61%
STEMPOINT CAPITAL LP 08/14/2026 182.38 K $3.28 M   100.00% 0.60%
UBS GROUP AG 08/13/2026 175.18 K $3.15 M   111.81% 0.57%
NORTHERN TRUST CORP 08/13/2026 138.78 K $2.50 M   705.49% 0.45%
EXOME ASSET MANAGEMENT LLC 08/14/2026 127.77 K $2.30 M   -16.60% 0.42%
SECTORAL ASSET MANAGEMENT INC 08/14/2026 121.30 K $2.18 M   100.00% 0.40%
WOODLINE PARTNERS LP 08/14/2026 94.49 K $1.70 M   27.69% 0.31%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 75.23 K $1.35 M   52.21% 0.25%
BURKEHILL GLOBAL MANAGEMENT, LP 08/14/2026 74.00 K $1.33 M   0.00% 0.24%
BLACKSTONE INC. 08/14/2026 62.65 K $1.13 M   100.00% 0.21%
SILVERARC CAPITAL MANAGEMENT, LLC 08/13/2026 59.10 K $1.06 M   -54.71% 0.19%
Y-INTERCEPT (HONG KONG) LTD 07/14/2026 50.82 K $914.83 K   100.00% 0.17%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 08/14/2026 50.26 K $904.64 K   100.00% 0.16%
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. 08/14/2026 50.26 K $904.64 K   100.00% 0.16%
NUVEEN, LLC 08/11/2026 47.63 K $857.32 K   100.00% 0.16%
BANK OF NEW YORK MELLON CORP 08/06/2026 45.78 K $824.00 K   100.00% 0.15%
STONEPINE CAPITAL MANAGEMENT, LLC 08/17/2026 40.00 K $720.00 K   -52.94% 0.13%
BANK OF AMERICA CORP /DE/ 08/14/2026 25.82 K $464.78 K   -11.80% 0.08%
RHUMBLINE ADVISERS 08/12/2026 25.49 K $458.77 K   100.00% 0.08%
MOORE CAPITAL MANAGEMENT, LP 08/14/2026 25.00 K $450.00 K   0.00% 0.08%
SQUAREPOINT OPS LLC 08/14/2026 24.17 K $434.99 K   100.00% 0.08%
AMERICAN CENTURY COMPANIES INC 08/12/2026 22.81 K $410.49 K   100.00% 0.07%
WELLS FARGO & COMPANY/MN 08/14/2026 19.70 K $354.60 K   100.00% 0.06%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 18.28 K $328.95 K   -63.65% 0.06%
VIRTUS INVESTMENT ADVISERS, INC. 08/11/2026 18.26 K $328.64 K   100.00% 0.06%

Crescent Biopharma Inc. institutional Ownership - FAQ's

During the previous two years, 107 institutional investors and hedge funds held shares of Crescent Biopharma Inc.. The most heavily invested institutionals were:

FMR LLC: 4.13 M

BVF INC/IL: 2.75 M

Fairmount Funds Management LLC: 2.75 M

VR Adviser, LLC: 2.13 M

Logos Global Management LP: 1.9 M

FCPM III SERVICES B.V.: 1.68 M

95.52% of Crescent Biopharma Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 30.06 M shares in the last 24 months. This purchase volume represents approximately $361.33 M in transactions.